PD-L1 is upregulated on the surface of many types of cancer cells by IFN-γ and TNF-α, and the regulation involves some endogenous carcinogenic pathways (e.g., the PI3K-AKT and AMPK pathways). The gene discussed is IFNG; the disease is cancer.